Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Bristol To Link Up With VantAI On Molecular Glue Therapies

14 Feb 2024

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Content

Deal Watch: Lilly Will Take Over Beam’s Rights To Verve Cardiovascular Assets

01 Nov 2023

SpringWorks’ Ogsiveo Is First-Ever US FDA-Approved Drug For Desmoid Tumors

29 Nov 2023

Deal Watch: Sangamo Inks Significant Option Deal With Prevail After Losing Tie-Ups With Novartis, Biogen

18 Jul 2023

For Sale, Buyer Sought: Teva Confirms API Unit Is On The Block

01 Feb 2024

Private Equity Firm Acquires Irish Generics Player Chanelle

14 Feb 2024

Gedeon Richter Investment In Formycon Opens Up Collaboration Opportunities

12 Feb 2024

USP And Dexcel Pick Up Teva OTC Brands

31 Jan 2024

Sandoz Plugs Ophthalmology Gap With Coherus Ranibizumab Deal

22 Jan 2024

Deal Watch: Bristol Accesses Tech Platforms From SyntheX, Autolus

05 Oct 2022

Repare Gets Cash And Validation In DNA Damage Repair Alliance With Roche

02 Jun 2022

Deal Watch: Dragonfly Adds Gilead To Its List Of Big-Name Partners

02 May 2022

Gilead Offers Up $4.3bn For CymaBay And Phase III PBC Candidate

12 Feb 2024

Gilead Increases Investment In Arcus; Firms Abandon Chemo-Free Combo Study

30 Jan 2024

Roivant Shopping For Multiple, Transformative Deals

13 Feb 2024

Autolus Gets Cash From BioNTech, Which Gets Manufacturing And Options

08 Feb 2024

Resilient Redx Inks Jazz KRAS Pact

07 Feb 2024

Novartis Makes An Ideal Match For MorphoSys

06 Feb 2024

Leo Looks For More Deals After Sealing Timber Buy

24 Jan 2024

Novo Nordisk Bets $256m On Mystery Molecule

24 Jan 2024

J&J Has An Appetite For Pharma M&A, But Knows What It Likes

23 Jan 2024

Sanofi Ramps Up In Rare Diseases With Inhibrx Buy

23 Jan 2024

Genentech Places Bet On Polymer Nanoparticle-Based Delivery With GenEdit Deal

23 Jan 2024

Roche Takes Out The Alzheimer’s Trash

22 Jan 2024

One Plus One Equals Three For Calluna

29 Jan 2024

It’s All About Abecma As 2seventy Sells Off Pipeline To Regeneron In Restructuring

30 Jan 2024

Fewer Acquisitions And Alliances In 2023, But Valuations Increased

05 Feb 2024

Novo Splashes Out Again To Solve Semaglutide Supply Problem

05 Feb 2024

Novartis Keen On Cardio Deals But Obesity Ship Has Sailed

31 Jan 2024

Related Companies

Bristol Myers Squibb Company

VantAI

Boehringer Ingelheim GmbH

Janssen Pharmaceutical Cos.

SyntheX

Evotec SE

BioVaxys Technology Corp.

IMV Inc.

Immunome Inc.

Ayala Pharmaceuticals, Inc.

Nascent Biotech, Inc.

Manhattan BioSolutions, Inc.

AVROBIO, Inc.

Synthekine Inc.

Sanofi

INVO Bioscience®

University of Miami

Bascom Palmer Eye Institute

GSK plc

Repare Therapeutics, Inc.

Roche Holding AG

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.